Type 2 Diabetes Mellitus (T2DM) Clinical Trials

18 studies are recruiting for type 2 diabetes mellitus (t2dm) in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies now recruiting

  1. A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus

    The purpose of this study is to evaluate the effect of a single dose of ALN-4324 on whole-body insulin sensitivity in participants with T2DM

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    Clinical Trial Site, Chula Vista, California
    Run by
    Alnylam Pharmaceuticals
  2. Integrating New Skills Into Diabetes Education With CGM

    This study is designed to test the preliminary efficacy of a three-stage continuous glucose monitor (CGM) integration program for older adults who are taking insulin. This study will learn if a three-stage CGM integration program ("intervention") that includes sessions focused on CGM technology ski…

    Stage
    Not phased
    Ages
    65 and older
    Site
    University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
    Run by
    University of North Carolina, Chapel Hill
  3. The GRoceries Aimed at Increasing Nutrition Study

    Only 2% of Americans meet the recommended levels of whole grain consumption, despite its association with reduced risk of type 2 diabetes. This study aims to assess if consumers with prediabetes or type 2 diabetes can be encouraged to switch from buying refined grain products to whole grain product…

    Stage
    Not phased
    Ages
    45 to 70
    Site
    University of Pennsylvania, Philadelphia, Pennsylvania
    Run by
    University of Pennsylvania
  4. Human Immunodeficiency Virus (HIV) Food Insecurities

    The objectives of this study are to better understand how FI (food insecurities) contributes to the development of cardiometabolic comorbidities among PWH (People with HIV) and to test a novel bilingual FI intervention designed to reduce these comorbidities among food insecure PWH. The PI and staff…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Wake Forest Health Sciences, Winston-Salem, North Carolina
    Run by
    Wake Forest University Health Sciences
  5. Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes

    The investigators are hoping to determine whether tailoring the diet of someone with type 2 diabetes to their ethnic group while following American Diabetes Association guidelines can make a significant difference in their blood sugar controls. Participants will be required to wear a Continuous Glu…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Stanford University, Stanford, California
    Run by
    Stanford University
  6. Time Restricted Eating in Patients With Microalbuminuria

    This is a clinical trial to assess how time-restricted eating (TRE) may improve kidney health and filtration patients with type 2 diabetes and increased protein content in their urine. All participants will be participating in TRE in which they follow a consistent 8-10 hour eating window everyday.

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Altman Clinical and Translational Research Institute, La Jolla, California
    Run by
    University of California, San Diego
  7. Achieving Routine Intervention and Screening for Emotional Health

    The purpose of this project is to evaluate the effectiveness of diabetes distress screening and intervention on patients with type 2 diabetes mellitus (T2DM).

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Chicago, Chicago, Illinois
    Run by
    University of Chicago
  8. CGM for Management of Type 2 Diabetes in Pregnancy

    The goal of this clinical trial is to learn if continuous glucose monitoring works better than self-monitoring of blood glucose (fingersticks) to treat type 2 diabetes in pregnancy. It will also learn about all risk factors (biologic, personal, social) for maternal and infant complications in type …

    Stage
    Not phased
    Ages
    18 to 50
    Site
    University of Alabama at Birmingham, Birmingham, Alabama
    Locations
    7 in total
    Run by
    University of Alabama at Birmingham
  9. Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

    IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Alabama, Birmingham, Alabama
    Locations
    7 in total
    Run by
    Duke University
  10. Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

    IRIS-CKD is a two-program implementation study to improve guideline-recommended screening and treatment of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Alabama, Birmingham, Alabama
    Locations
    7 in total
    Run by
    Duke University
  11. Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes

    People with high blood pressure and diabetes often have low levels of key nutrients as a result of not eating enough fresh fruits and vegetables. Research studies suggest that these nutrients can lower blood pressure and blood sugar. This study will investigate if providing encouragement to adopt t…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Johns Hopkins ProHealth Clinical Research Unit, Baltimore, Maryland
    Run by
    Johns Hopkins University
  12. Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

    This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Vanderbilt University Medical Center, Nashville, Tennessee
    Run by
    Vanderbilt University Medical Center
  13. Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults

    Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitato…

    Stage
    Not phased
    Ages
    18 to 45
    Site
    Scripps Health, San Diego, California
    Run by
    San Diego State University
  14. CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes

    The purpose of this study is to compare patient adherence to blood sugar monitoring during pregnancy using two different measurement methods in pregnancies complicated by pregestational type 2 diabetes (T2DM). Pregnant patients with T2DM are at risk of having larger babies, babies with low sugar le…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Jefferson Health New Jersey, Sewell, New Jersey
    Locations
    2 in total
    Run by
    Thomas Jefferson University
  15. Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.

    DOVE-MET-COME-100 is a single site prescreening survey study designed to identify adults who may be eligible for future industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, current heal…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Clindove Research LLC, Brooklyn, New York
    Run by
    Clindove Research LLC
  16. Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

    The goal of this investigational study is to evaluate the safety and clinical performance of Tropocells Autologous Platelet-rich Fibrin (PRF) for wound care for both males and females, ages 18-80 years old, with Grade 1 and 2, mild to moderate, neuroischemic diabetic chronic foot ulcers in subjects…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    WoundCentrics Wound Care & Hyperbarics -Corpus Christi - Shoreline, Corpus Christi, Texas
    Locations
    2 in total
    Run by
    Estar Medical dba Medical Technologies, LTD
  17. Low-Dose Pioglitazone in Patients With NASH (AIM 2)

    To determine the safety and efficacy of low-dose pioglitazone (15 mg per day) on liver histology in in patients with T2DM with biopsy-proven nonalcoholic steatohepatitis (NASH).

    Stage
    Phase 2
    Ages
    21 to 75
    Site
    University of Florida, Gainesville, Florida
    Run by
    University of Florida
  18. RCT Glargine vs NPH for Treatment of DM in Pregnancy

    We are asking you to take part in this research study because you are diagnosed with pregestational Type 2 Diabetes Mellitus or Gestational Diabetes Mellitus requiring insulin therapy in pregnancy. Currently, many hospitals differ among use of insulin for management of DM in pregnancy, with NPH, gl…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Loyola University Medical Center, Maywood, Illinois
    Run by
    Loyola University

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.